# UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program-Evaluation Supplement

> **NIH NIH T32** · UNIV OF NORTH CAROLINA CHAPEL HILL · 2020 · $86,400

## Abstract

ABSTRACT
The University of North Carolina at Chapel Hill (UNC), in collaboration with Duke University and the Hamner-
UNC Institute for Drug Safety Sciences (IDSS), has a successful T32 training program in clinical pharmacology
that builds on our exceptional research environment with world-class programs in drug discovery, drug
development, pediatric clinical pharmacology, pharmacogenomics, and drug safety. We have an outstanding
track record of training clinician-scientists in clinical pharmacology and an excellent and diverse applicant pool
with many more qualified applicants than funded positions. Our training program detailed in this renewal
application offers strong leadership, internationally-recognized mentors from multiple disciplines who are
actively involved in clinical pharmacology, a wide-array of cutting edge technologies and resources, and a
uniquely collaborative environment with strong institutional support. The national applicant pool for this
program is derived both from MDs in medical specialty training programs seeking a career path in clinical
pharmacology and PharmDs in advanced clinical/translational research training. Trainees, guided by
individualized mentoring teams, complete clinical pharmacology coursework and engage in program-specific
activities to gain expertise in all aspects of contemporary clinical pharmacology research, from
pharmacokinetics, pharmacometrics and pharmacogenomics to clinical trial design and ethics. Faculty mentors
are chosen based on their research productivity in at least one of four focus areas that form the core of this
training program: Drug Disposition and Action; Quantitative Pharmacology and Clinical Trial Design;
Pharmacogenomics; Drug-induced Organ Toxicity. A unique feature of this training program is our focus on
understudied areas in clinical pharmacology, specifically pediatrics and drug safety. The keen interest in
clinical pharmacology within our trainee pool, the unparalleled investment in clinical pharmacology research
resources at all three institutions, the intellectually-rich biomedical science environment of Research Triangle
Park, and our longstanding excellent research and training infrastructure combine to create a moment of
unsurpassed opportunity for training in clinical pharmacology.

## Key facts

- **NIH application ID:** 10146127
- **Project number:** 3T32GM086330-10S1
- **Recipient organization:** UNIV OF NORTH CAROLINA CHAPEL HILL
- **Principal Investigator:** KIM L.R. BROUWER
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $86,400
- **Award type:** 3
- **Project period:** 2011-07-01 → 2021-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10146127

## Citation

> US National Institutes of Health, RePORTER application 10146127, UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program-Evaluation Supplement (3T32GM086330-10S1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10146127. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*